المؤلفون: Jingtao Xu, Rui Zhao, Ye Xue, Huanqin Xiao, Yanliang Sheng, Dong Zhao, Jietao He, Hongyan Huang, Qi Wang, Huijun Wang

المصدر: Forensic Sciences Research, Vol 3, Iss 2, Pp 153-160 (2018)

مصطلحات موضوعية: Forensic pathology, skin contusion, vital reaction, RNA-seq, differentially expressed genes, Criminal law and procedure, K5000-5582, Public aspects of medicine, RA1-1270

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2096-1790; https://doaj.org/toc/2471-1411

URL الوصول: https://doaj.org/article/b28b5f344c714f52ba16bbe5b1eb139a

المؤلفون: Jie-Tao He, Qi Wang, Jing-Tao Xu, Ye Xue, Dong Zhao, Huijun Wang, Rui Zhao, Hong-Yan Huang, Huan-Qin Xiao, Yanliang Sheng

المصدر: Forensic Sciences Research, Vol 3, Iss 2, Pp 153-160 (2018)
Forensic sciences research

مصطلحات موضوعية: 0301 basic medicine, differentially expressed genes, Chemokine, vital reaction, RNA-Seq, Biochemistry, Genetics and Molecular Biology (miscellaneous), Forensic pathology, Pathology and Forensic Medicine, Analytical Chemistry, Transcriptome, 03 medical and health sciences, 0302 clinical medicine, Immune system, Gene expression, 030216 legal & forensic medicine, lcsh:K5000-5582, Physical and Theoretical Chemistry, KEGG, Gene, Genetics, biology, lcsh:Public aspects of medicine, lcsh:RA1-1270, Hedgehog signaling pathway, Psychiatry and Mental health, 030104 developmental biology, Anthropology, biology.protein, skin contusion, lcsh:Criminal law and procedure, Original Article, RNA-seq

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32bcfe7c4361fa20b4f68840ce48733a
https://doi.org/10.1080/20961790.2017.1349639

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
LibKey Link

المؤلفون: Xu J; Department of Forensic Pathology, School of Forensic Mecicine, Southern Medical University, Guangzhou, China., Zhao R; Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang, China., Xue Y; Department of Forensic Pathology, School of Forensic Mecicine, Southern Medical University, Guangzhou, China., Xiao H; Department of Pathology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China., Sheng Y; Department of Forensic Medicine, School of Basic Medicine, Jiamusi University, Jiamusi, China., Zhao D; CollaborativeInnovation Center of Judicial Civilization, China and Key Laboratory of Evidence Science, China University of Political Science and Law, Ministry of Education, Beijing, China., He J; Department of Forensic Pathology, School of Forensic Mecicine, Southern Medical University, Guangzhou, China., Huang H; Department of Forensic Pathology, School of Forensic Mecicine, Southern Medical University, Guangzhou, China., Wang Q; Department of Forensic Pathology, School of Forensic Mecicine, Southern Medical University, Guangzhou, China., Wang H; Department of Forensic Pathology, School of Forensic Mecicine, Southern Medical University, Guangzhou, China.

المصدر: Forensic sciences research [Forensic Sci Res] 2017 Jul 18; Vol. 3 (2), pp. 153-160. Date of Electronic Publication: 2017 Jul 18 (Print Publication: 2018).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101724928 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-1411 (Electronic) Linking ISSN: 24711411 NLM ISO Abbreviation: Forensic Sci Res Subsets: PubMed not MEDLINE